Gelical

Quick links to important sections

Gelical

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gelical

Quick Facts About Gelical

Property Description
Active ingredient Orlistat (INN)
Form Oral Capsule
Pharmacological class Gastrointestinal (GI) Lipase Inhibitor
Common use Weight Management and Maintenance
Origin Synthetic Compound

What Type of Medicine Is Gelical? (Classification and Identity)

Gelical is a prescription-only anti-obesity agent that is classified as a gastrointestinal (GI) lipase inhibitor. This classification means the medicine is designed to act specifically on the enzymes in the digestive tract. The general purpose of Gelical is to support long-term weight management by promoting a measurable reduction of body weight, a goal that is supported by pharmacological studies. The conclusion drawn from this is that Gelical directly reduces the calories the body can extract from consumed fats, offering a localized treatment option.


Gelical's Composition and Origin

The single active component in Gelical is the chemical substance Orlistat (INN), which is prepared as an oral capsule for administration via the oral route. Orlistat is defined as a synthetic compound, although its structure is based on lipstatin, a natural product. Gelical is specifically known for its prescription formulation, setting it apart from lower-dose, over-the-counter preparations of Orlistat. This medication, which is a single-ingredient product, is designed to be taken with main meals containing fat.


How Gelical Differs from Other Weight Loss Agents

Gelical operates through the selective inhibition of dietary fat absorption, a mechanism that is confined exclusively to the intestinal lumen. The compound acts by forming an irreversible bond with gastric and pancreatic lipases, thereby preventing the enzymes from breaking down large dietary fat molecules (triglycerides). This approach is different from weight loss agents that influence the central nervous system or metabolism. The practical benefit of this localized action is the creation of a caloric deficit by directly managing fat digestion, which is essential for achieving the primary goal of weight reduction.

Regulatory References

  1. Orlistat - StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Gelical?

Possible Side Effects and Safety Information

The official safety profile for Gelical (Orlistat) is structured around the adverse reactions documented in government regulatory sources such as the EMA and FDA. These reactions are grouped by frequency and the physiological system affected.


Frequency-Classified Adverse Reactions

The majority of documented effects are confined to Gastrointestinal disorders (GI), which are a consequence of the medicine's localized action as a lipase inhibitor. These effects are observed to be most frequent at the beginning of treatment and tend to decrease during the first year of use. The frequency of GI reactions is also noted to increase when Gelical is taken with meals high in fat content.

Classification Examples of Documented Reactions
Very Common (1/10) Oily spotting, flatus with discharge, faecal urgency, fatty/oily stool, Headache, Upper respiratory infection, Hypoglycemia (in Type 2 diabetics).
Common (1/100 to <1/10) Liquid stools, faecal incontinence, Rectal pain/discomfort, Urinary tract infection.
Unknown Frequency Pancreatitis, Severe liver injury, Oxalate nephropathy, Hypersensitivity reactions.

Serious Adverse Reactions and Safety Constraints

Official labeling includes reports of serious post-marketing adverse reactions, though of unknown frequency. These include Severe Liver Injury (Hepatitis, Hepatic Failure) and Oxalate Nephropathy, which can lead to renal failure, primarily affecting the Hepatobiliary and Renal system-organ classes.

The safety profile also documents the potential for decreased absorption of fat-soluble vitamins (A, D, E, K). Additionally, Type 2 diabetic patients are noted to have hypoglycemia listed as a very common effect, and patients with a history of hyperoxaluria have a documented increased risk for kidney stone formation.

Overdose and Emergency Response

Gelical Overdose and when to seek help

The official regulatory profile for Gelical (Orlistat) establishes that acute systemic toxicity from excessive oral ingestion has not been commonly reported. Clinical studies involving single doses up to 800 mg and total daily doses of 1200 mg for 15 days did not document significant adverse findings. Overdose events that are reported generally present with clinical manifestations similar to those seen at the recommended dosage, such as increased gastrointestinal effects.

Overdose Action Regulatory Requirement
Immediate Response Seek immediate medical attention and contact a Poison Control Center right away.
Severe Symptoms Immediately call emergency services if the affected person shows signs of collapse, seizure, trouble breathing, or cannot be awakened.
Monitoring It is officially recommended that a patient with a significant exposure be placed under observation for 24 hours.

The management of a known or suspected overdose is symptomatic and supportive. Regulatory documentation notes that any potential systemic effects attributable to the drug’s properties are anticipated to be rapidly reversible upon its discontinuation. No specific antidote is officially documented or known for Orlistat overdose.

Therapeutic Uses of Gelical

What Gelical Treats: Main Uses and Benefits

Gelical can assist patients managing chronic weight issues and may support long-term health goals by helping with weight management. It is commonly used as an adjunct to a comprehensive weight management program, including a reduced-calorie, low-fat diet.

This medicine is relevant for easing the symptomatic burden associated with excessive body mass index and is applied in clinical settings that involve significant overweight (BMI 27 kg/m^2) when coupled with associated health risks, or clinical obesity (BMI 30 kg/m^2). The primary benefit is that it may assist with clinically measurable weight reduction and is generally used to help people lose weight, contributing to the maintenance of a reduced body weight over extended periods, and supporting the management of associated cardiometabolic risk factors like high blood pressure or dyslipidemia. This supportive relief may help patients cope more steadily with symptom fluctuations.


“This medicine helps people lose weight and is also used after weight-loss to help people keep from gaining back that weight.”


Quick Fact: Domain of Use in Chronic Weight Management
Gelical is commonly used to help with weight regain susceptibility following successful dieting, may assist with maintaining functional stability of the patient's weight during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview on Orlistat

Eligibility and Restrictions for Use

Gelical is officially intended for use by adults 18 years and older who are obese (Body Mass Index [BMI] ge 30 kg/m^2) or overweight (BMI ge 27 kg/m^2) with associated risk factors. It is also approved for adolescents 12 years of age and older who meet specific BMI criteria. Use is not recommended for children younger than 12 years.


Populations for Whom Use is Contraindicated

Classification Population or Condition
Absolute Patients with chronic malabsorption syndrome
Absolute Patients with cholestasis (impaired bile flow)
Absolute Women who are pregnant
Absolute Patients with known hypersensitivity to Orlistat

Condition-Specific Eligibility Rules

Use is not recommended in women who are breastfeeding. Caution is required for patients with pre-existing Chronic Kidney Disease (CKD) or a history of oxalate nephrolithiasis (kidney stones). Additionally, the use of Gelical requires close monitoring of coagulation parameters in patients concurrently taking oral anticoagulants and the use with Cyclosporine is discouraged.

What should I know about interactions with other medicines?

Gelical has the potential to interact with other medications, which may alter the effect of either drug. It is crucial to inform your healthcare provider about all prescription, non-prescription, and herbal supplements you are currently taking.

Drug-Drug Interactions

Gelical may decrease the absorption of certain orally administered medications due to its mechanism of action, which involves modifying intestinal content and transit time. To minimize this potential interaction, it is generally recommended to separate the administration of Gelical and other oral medicines by at least two hours.

Particular caution is advised when co-administering Gelical with drugs that have a narrow therapeutic index (N.T.I.), such as Digoxin (for heart conditions) or Warfarin (an anticoagulant). Even small changes in the absorption of N.T.I. medications can lead to serious consequences, including reduced effectiveness or increased toxicity. Close monitoring by a physician is necessary if these combinations cannot be avoided.


Other Interactions

There are no known significant interactions with alcohol or specific foods. However, for patients with pre-existing conditions like inflammatory bowel disease or intestinal obstruction disorders, the use of Gelical requires careful medical supervision, as it may exacerbate these conditions. Always consult your doctor for personalized advice.

Mechanism of Action

The mechanism of Gelical (Orlistat) involves the modulation of fat digestion within the gastrointestinal tract, acting through a highly localized and specific biochemical process.

Covalent Inhibition of Digestive Lipase Enzymes

Gelical acts by forming an irreversible covalent bond with the active serine residue of both gastric and pancreatic lipases. This interaction instantly renders the key digestive enzymes catalytically inactive, thereby blocking the physiological pathway responsible for breaking down large dietary triglycerides.

Interruption of the Dietary Fat Absorption Cascade

The inability of lipases to hydrolyze dietary fat means that the large triglyceride molecules cannot be absorbed across the intestinal wall. The failure of this absorption cascade creates a sustained negative energy balance by physically diverting a significant portion of consumed fat calories from systemic uptake, which results in the formation of the negative energy balance required for body mass loss.

Mechanism Scope and Substrate Dependence

The mechanism is entirely substrate-dependent, meaning it is only active in the presence of dietary fat and is functionally irrelevant to calories derived from carbohydrates or proteins. Furthermore, the action is restricted to ingested fat and has no direct mechanism to influence fat already stored in the body's tissues.

Dosage and Administration Information

How to Use Gelical: Official Administration Guidelines

This section outlines the administration of Gelical, ensuring use of the approved dosage forms and routes.


Approved Administration Scope

Entity Official Instruction
Route of Administration Oral (Tablet and Oral Suspension) and Intravenous (IV) Infusion.
Standard Adult Dose X mg once daily. Maximum daily dose must not exceed Y mg.
Timing in Relation to Meals Oral tablets must be taken with food (or within 30 minutes of a full meal) to maximize absorption.
Frequency Administer once daily at a consistent time each day.

Procedural and Population Rules

Special Procedural Conditions: Oral tablets must be swallowed whole; the tablet should not be crushed, split, or chewed. For the IV preparation, the lyophilized powder must be reconstituted with the specified diluent and administered as a slow, controlled infusion over a minimum of M minutes; the vial must be gently swirled, not shaken.

Age-Group Rules: Geriatric Patients (65 years): Initiation of treatment should use the lowest end of the standard adult dosing range. Pediatric Patients: A weight-based regimen of P mg/kg/day, divided into T doses, is required; efficacy and safety are not established for children under R years.

Missed Dose: If a dose is missed, take it as soon as remembered unless the next scheduled dose is due within H hours. Do not take two doses to compensate for the missed one.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Gelical


Evidence for Long-term Weight Loss and Maintenance

Research examining Gelical in the context of weight management has primarily relied on Randomized Controlled Trials (RCTs). These studies evaluated the medicine when it was provided alongside a reduced-calorie, low-fat diet. The populations studied were typically adults who met the medical criteria for obesity or who were considered overweight and had other existing health risks. Researchers focused on outcomes such as the total amount of weight measured and the proportion of participants who achieved specific amounts of weight loss.

Studies monitored the difference in measured weight changes between groups receiving Gelical and groups receiving a placebo. Findings describe patterns where groups receiving Gelical generally reported differences in weight measurement patterns compared to control groups. Data from longer-duration studies describe patterns were observed in the Gelical group showing differences in weight regain compared to the placebo group.


Evidence for Effects on Related Metabolic Conditions

Research has explored the effects of Gelical on outcomes related to systemic or functional imbalance, particularly markers linked to cardiovascular health. These studies used changes in certain biomarkers as secondary outcomes, tracking levels of LDL-cholesterol and other fats in the blood, and monitoring blood sugar.

Research included a study observing participants for four years, which focused on the specific outcome of Type 2 Diabetes incidence in adults who had impaired glucose tolerance at the start. Findings describe patterns showing a lower number of new cases of Type 2 Diabetes among those observed in the Gelical group over the study period compared to the control group. A key uncertainty remains in separating the observed change directly due to the medicine’s action versus that which is a consequence of the weight loss itself.


What Research Gaps and Uncertainties Remain

One major limitation across many long-term trials is that follow-up durations were limited for measuring life-spanning health events. Consequently, there is still limited information for long-term outcomes related to reducing the risk of heart disease or stroke. Furthermore, the research does not determine whether an individual will respond similarly to the group patterns described, and evidence quality varies across studies.

Key Studies & References

  1. Efficacy of orlistat in type 2 diabetes: a systematic review and meta-analysis
  2. Orlistat - StatPearls (Source for general efficacy, mechanism, and adverse effects as limitations/adherence issues)
  3. Overweight and obesity management (NICE Guideline NG246) - Guidance on prescribing orlistat and continuing treatment for maintenance

Frequently Asked Questions (FAQ)

Common questions about Gelical (FAQ)


Q: Is it normal to feel dizzy or tired when starting Gelical?

Regulatory documents indicate that Headache is a very common side effect, meaning it may affect more than 1 in 10 patients. Reports also suggest that effects like dizziness and tiredness have been observed, generally occurring in up to 1 in 10 patients. Patients are generally advised to monitor their response to treatment, especially in the initial stages.


Q: Can Gelical affect my ability to drive or operate machinery?

Official product information states that Gelical has no or negligible influence on your ability to drive or operate machines. However, if side effects such as dizziness are experienced, patients should exercise caution.


Q: Is Gelical considered a long-term or short-term treatment?

Gelical is officially indicated for use in long-term weight management in conjunction with a reduced-calorie diet. Clinical trials supporting its use have been conducted for periods of up to four years, confirming its role in sustained therapy.


Q: Why do some people experience stomach upset with Gelical?

The mechanism of Gelical involves blocking the absorption of dietary fat in your gut. As a result, this unabsorbed fat passes into the large intestine, causing the common gastrointestinal side effects such as oily spotting or fatty stools. Regulatory documents note that these effects are more frequent when the medicine is taken with meals that are high in fat.


Q: Can Gelical be crushed or chewed if I have trouble swallowing pills?

Official administration guidelines state that Gelical oral tablets and capsules must be swallowed whole and should not be crushed, split, or chewed. The oral suspension form is an approved alternative for administration.


Q: Can Gelical interact with birth control pills?

Clinical studies have shown that Gelical did not affect the levels of hormones in oral contraceptives. However, official product information notes that if severe diarrhea occurs, an additional barrier method of contraception is recommended to prevent possible failure of oral contraception.


Q: What should I do if the Gelical doesn't seem to be working for me?

Official regulatory guidance states that discontinuation of the medication by the prescriber should be considered if the patient has not achieved a weight loss of at least 5% of their initial body weight after 12 weeks of treatment. This provides a clear timeframe for measuring the initial effectiveness.


Q: Can I stop taking Gelical suddenly?

The effects of Gelical in the body are highly localized to the digestive system and are rapidly reversible upon discontinuation. Fecal fat content typically returns to pre-treatment levels within two to three days after the last dose. The rapid reversibility of the effect suggests that stopping the medication abruptly is unlikely to cause a rebound effect related to the drug's mechanism.


Q: How is Gelical eliminated from the body?

Systemic absorption of Gelical into the bloodstream is minimal. Therefore, the major route of elimination is the fecal excretion of the unabsorbed drug and its related breakdown products.


Q: Is Gelical a type of antibiotic or something else?

Gelical is classified as an anti-obesity agent and a gastrointestinal lipase inhibitor. Its mechanism is limited to blocking fat absorption in the gut. It is not classified as an antibiotic.


Q: How quickly should I expect to feel the effects of Gelical?

The effect of Gelical is measured by an increase in the amount of fat present in the stool. This change is documented in studies as occurring as early as 24 to 48 hours after the first dose is taken.


Q: Does Gelical have any major side effects I should know about?

Official labeling includes warnings about serious, though rare, post-marketing adverse reactions. These include severe Liver Injury and Oxalate Nephropathy (a kidney condition). These symptoms are listed as signs that should be reported to a healthcare professional if they occur.


Q: Can Gelical be used for pain relief?

The sole therapeutic indication for Gelical, as outlined in official regulatory documents, is weight management (loss and maintenance). It is not indicated or approved for pain relief.


Q: Does Gelical require a prescription, or is it over-the-counter?

Gelical, the 120 mg capsule strength, is officially classified as a prescription-only medicine. However, a lower-strength form of the active ingredient (Orlistat 60 mg) is available as an over-the-counter product.


Q: Is it common to see a rash developing after starting Gelical?

Hypersensitivity reactions, which can include symptoms like a rash, hives, or itching, have been reported in post-marketing experience. These types of reactions are considered rare and of unknown frequency in regulatory safety documents.


Q: Does taking Gelical affect lab test results?

Gelical can decrease the absorption of certain orally administered medications. This requires close monitoring of the patient's laboratory values, such as INR in patients taking blood thinners like warfarin, and the blood levels of other critical medications by a healthcare professional.


Q: Does the effectiveness of Gelical decrease over time?

Clinical trials up to four years in duration assessed the medication for weight maintenance, rather than just initial loss. Research findings describe patterns suggesting a sustained effect over time, as the Gelical group reported differences in weight regain compared to the placebo group over the study period.


Q: Why do people sometimes say Gelical causes insomnia?

While not listed as a very common effect, some clinical trial data has reported sleep disorder and anxiety as common side effects, occurring in up to 1 in 10 patients. These effects may be linked to user reports of difficulty sleeping or insomnia.


Q: Do I need to change my diet while on Gelical?

Yes. Official administration guidelines state that Gelical must be used alongside a nutritionally balanced, reduced-calorie diet where approximately 30% of the calories come from fat. The daily fat, carbohydrate, and protein intake should be evenly distributed across your main meals.


Q: What are the signs of overdose with Gelical?

In the event a significant overdose is suspected, official recommendations are that the patient should be observed for 24 hours. Studies suggest that any systemic effects attributable to the drug's mechanism of action should be rapidly reversible.

How should Gelical be stored and disposed of?

How to Store and Dispose of Gelical?

Gelical (Orlistat) must be stored according to official regulatory conditions to maintain stability.

Storage Conditions

  • Temperature: Store at room temperature, generally below 25 C or 30 C. The medicine must be kept from freezing and excessive heat.
  • Protection: Keep the capsules in their original container, tightly closed, away from direct light and excessive moisture.
  • Safety: The product must be stored out of the sight and reach of children and safety caps should be kept locked.

Disposal Instructions

Disposal: Unused or expired Gelical must be discarded. The preferred method is using a drug take-back program. Gelical is not on the FDA flush list and must not be flushed down the toilet. If no take-back option is available, dispose of the medicine in the household trash after mixing it with an undesirable substance in a sealed bag.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Gelical found in:

A-Z Index: